Khan Najat
CEO and President · 12 insider transactions on file
All transactions
| Date | Ticker | Company | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2026-06-05 | RXRX | RECURSION PHARMACEUTICALS, INC. | Sale | 23,588 | $3.58 | $84,459.19 | filing |
| 2026-05-15 | RXRX | RECURSION PHARMACEUTICALS, INC. | Tax withholding | 62,701 | $3.04 | $190,611.04 | filing |
| 2026-03-09 | RXRX | RECURSION PHARMACEUTICALS, INC. | Sale | 28,298 | $3.35 | $94,659.64 | filing |
| 2026-02-17 | RXRX | RECURSION PHARMACEUTICALS, INC. | Tax withholding | 14,280 | $3.49 | $49,837.20 | filing |
| 2026-02-06 | RXRX | RECURSION PHARMACEUTICALS, INC. | Tax withholding | 10,364 | $3.98 | $41,248.72 | filing |
| 2026-02-06 | RXRX | RECURSION PHARMACEUTICALS, INC. | Award | 30,346 | $0.00 | $0.00 | filing |
| 2026-02-06 | RXRX | RECURSION PHARMACEUTICALS, INC. | Award | 1,673,546 | $0.00 | $0.00 | filing |
| 2025-12-22 | RXRX | RECURSION PHARMACEUTICALS, INC. | Sale | 124,403 | $4.41 | $548,592.35 | filing |
| 2025-11-17 | RXRX | RECURSION PHARMACEUTICALS, INC. | Tax withholding | 17,584 | $4.14 | $72,797.76 | filing |
| 2025-11-05 | RXRX | RECURSION PHARMACEUTICALS, INC. | Award | 84,925 | $0.00 | $0.00 | filing |
| 2025-08-18 | RXRX | RECURSION PHARMACEUTICALS, INC. | Sale | 36,599 | $5.52 | $202,172.88 | filing |
| 2025-08-15 | RXRX | RECURSION PHARMACEUTICALS, INC. | Tax withholding | 3,789 | $5.64 | $21,369.96 | filing |
Insider transactions from SEC Form 4 filings via EDGAR. Names appear as filed and aren't normalized across issuers.